Search

Your search keyword '"Mercier, Benjamin D."' showing total 26 results
Start Over Author "Mercier, Benjamin D."
26 results on '"Mercier, Benjamin D."'

1. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research

Author

Ebrahimi, Hedyeh, Castro, Daniela V., Feng, Matthew I., Prajapati, Sweta R., Lee, Kyle O., Chan, Elyse H., Paul, Trishita, Sehgal, Ishaan, Patel, Jalen, Li, Xiaochan, Zengin, Zeynep B., Meza, Luis, Mercier, Benjamin D., Hsu, JoAnn, Govindarajan, Ameish, Chawla, Neal, Dizman, Nazli, Bergerot, Cristiane D., Rock, Adam, Liu, Sandy, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta K., and Chehrazi-Raffle, Alexander

Published
2023
Full Text
View/download PDF

3. CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)

Author

Ebrahimi, Hedyeh, primary, Lu, Kun-Han, additional, Castro, Daniela V, additional, Mercier, Benjamin D, additional, Dizman, Nazli, additional, Barragan-Carrillo, Regina, additional, Govindarajan, Ameish, additional, Meza, Luis, additional, Chawla, Neal S, additional, Hsu, JoAnn, additional, Chehrazi-Raffle, Alexander, additional, Tripathi, Abhishek, additional, Liu, Sandy, additional, Dorff, Tanya B, additional, Wah Wong, Chi, additional, Pal, Sumanta K, additional, and Zengin, Zeynep B, additional

Published
2023
Full Text
View/download PDF

4. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles

Author

Govindarajan, Ameish, primary, Salgia, Nicholas J., additional, Li, Haiqing, additional, Castro, Daniela V., additional, Mirzapoiazova, Tamara, additional, Armstrong, Brian, additional, Zhao, Dan, additional, Mercier, Benjamin D., additional, Dizman, Nazli, additional, Chawla, Neal, additional, Zengin, Zeynep, additional, Meza, Luis, additional, Tripathi, Nishita, additional, Sayegh, Nicolas, additional, Chehrazi-Raffle, Alex, additional, Tripathi, Abhishek, additional, and Pal, Sumanta K., additional

Published
2023
Full Text
View/download PDF

5. Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy

Author

Castro, Daniela V., primary, Prajapati, Sweta R., additional, Feng, Matthew I., additional, Chan, Elyse H., additional, Lee, Kyle O., additional, Paul, Trishita, additional, Sehgal, Ishaan, additional, Patel, Jalen, additional, Li, Xiaochen, additional, Zengin, Zeynep B., additional, Ebrahimi, Hedyeh, additional, Govindarajan, Ameish, additional, Meza, Luis, additional, Mercier, Benjamin D., additional, Chawla, Neal S., additional, Dizman, Nazli, additional, Philip, Errol J., additional, Hsu, JoAnn, additional, Bergerot, Cristiane D., additional, Chehrazi‐Raffle, Alex, additional, Rock, Adam, additional, Liu, Sandy, additional, Tripathi, Abhishek, additional, Dorff, Tanya B., additional, and Pal, Sumanta K., additional

Published
2023
Full Text
View/download PDF

6. Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.

Author

Castro, Daniela V., Prajapati, Sweta R., Feng, Matthew I., Chan, Elyse H., Lee, Kyle O., Paul, Trishita, Sehgal, Ishaan, Patel, Jalen, Li, Xiaochen, Zengin, Zeynep B., Ebrahimi, Hedyeh, Govindarajan, Ameish, Meza, Luis, Mercier, Benjamin D., Chawla, Neal S., Dizman, Nazli, Philip, Errol J., Hsu, JoAnn, Bergerot, Cristiane D., and Chehrazi‐Raffle, Alex

Subjects
RENAL cell carcinoma, HEPATITIS C virus, HEPATITIS B virus, HIV, HIV infections
Abstract

Objectives: To characterise the restrictiveness of eligibility criteria in contemporary renal cell carcinoma (RCC) trials, using recommendations from the American Society of Clinical Oncology (ASCO)‐Friends of Cancer Research (FCR) initiative. Methods: vPhase I–III trials assessing systemic therapies in patients with RCC starting between 30 June 2012 and 30 June 2022 were identified. Eligibility criteria regarding brain metastases, prior or concurrent malignancies, hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and human immunodeficiency virus (HIV) infection were identified and stratified into three groups: exclusion, conditional inclusion, and not reported. Descriptive statistics were used to determine the frequency of eligibility criteria. Fisher's exact test or chi‐square test were used to calculate their associations with certain trial characteristics. Results: A total of 423 RCC trials were initially identified of which 112 (26.5%) had sufficient accessible information. Exclusion of patients with HIV infection, HBV/HCV infection, brain metastases, and prior or concurrent malignancies were reported in 74.1%, 53.6%, 33.0%, and 8.0% of trials, respectively. In the context of HIV and HBV/HCV infection, patients were largely excluded from trials evaluating immunotherapy (94.4% and 77.8%, respectively). In addition, brain metastases were excluded in trials assessing targeted therapy (36.4%), combined therapy (33.3%), and immunotherapy (22.2%). Exclusion of patients with prior or concurrent malignancies was less frequently reported, accounting for 9.1%, 8.3%, and 5.6% targeted therapy, combined therapy and immunotherapy trials, respectively. Conclusion: A substantial proportion of RCC trials utilise restrictive eligibility criteria, excluding patients with fairly prevalent comorbidities. Implementing the ASCO‐FCR recommendations will ensure resulting data are more inclusive and aligned with patient populations in the real‐world. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

Author

Barragan-Carrillo, Regina, Chawla, Neal Shiv, Salgia, Nicholas, Meza, Luis A, Zengin, Zeynep Busra, Li, Xiaochen, Dizman, Nazli, Ebrahimi, Hedyeh, Hsu, Joann, Castro, Daniela V., Mercier, Benjamin D., Dorff, Tanya B., Tripathi, Abhishek, Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Chehrazi-Raffle, Alex, and Pal, Sumanta Kumar

Published
2024
Full Text
View/download PDF

8. Adherence to American Society of Clinical Oncology (ASCO) language of respect (LoR) guidelines in ASCO Annual Meeting prostate cancer (PCa) abstracts.

Author

Barragan-Carrillo, Regina, Wong, Megan Hoikei, Dizman, Nazli, Castro, Daniela V., Mercier, Benjamin D., Li, Xiaochen, Faridi, Amber, Goud, Jaya, Paul, Trishita, Chan, Ethan, Dukkipati, Akasha, Paul, Teebro, Zugman, Miguel, Ebrahimi, Hedyeh, Dorff, Tanya B., Chehrazi-Raffle, Alex, Pal, Sumanta Kumar, Florez, Narjust, and Prowell, Tatiana Michelle

Published
2024
Full Text
View/download PDF

9. Clinical and molecular characterization of urothelial (UC) vs. small cell carcinoma (SCC) of the urinary tract.

Author

Chawla, Neal Shiv, Mercier, Benjamin D., Govindarajan, Ameish, Li, Xiaochen, Castro, Daniela V., Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Zang, Peter D., LeVee, Alexis Ann, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, Salgia, Nicholas, Chehrazi-Raffle, Alex, Dorff, Tanya B., Pal, Sumanta Kumar, and Tripathi, Abhishek

Published
2024
Full Text
View/download PDF

10. Impact of insurance payer status (IS) on practice patterns and overall survival (OS) in patients (pts) with metastatic urothelial carcinoma (mUC).

Author

Mercier, Benjamin D., Tripathi, Nishita, Govindarajan, Ameish, Gebrael, Georges, Narang, Arshit, Li, Xiaochen, Castro, Daniela V., Chehrazi-Raffle, Alex, Dizman, Nazli, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Hsu, Joann, Bergerot, Cristiane Decat, Barragan-Carrillo, Regina, Zengin, Zeynep Busra, Meza, Luis A, Pal, Sumanta Kumar, Agarwal, Neeraj, and Tripathi, Abhishek

Published
2024
Full Text
View/download PDF

11. Adherence to ASCO Language of Respect (LoR) guidelines in urothelial carcinoma (UC) abstracts at the 2023 ASCO Annual Meeting.

Author

Castro, Daniela V., Mercier, Benjamin D., Zugman, Miguel, Li, Xiaochen, Barragan-Carrillo, Regina, Wong, Megan Hoikei, Chan, Ethan, Faridi, Amber, Goud, Jaya, Paul, Trishita, Dukkipati, Akasha, Patel, Jalen, Paul, Teebro, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Prowell, Tatiana Michelle, Florez, Narjust, Dizman, Nazli, and Pal, Sumanta Kumar

Published
2024
Full Text
View/download PDF

12. Evolution of the functionality of microbial communities in patients with metastatic renal cell carcinoma (mRCC) receiving cabozantinib (cabo)/nivolumab (nivo) with or without CBM588: A randomized clinical trial.

Author

Ebrahimi, Hedyeh, Meza, Luis A, Lee, Keehoon, Malhotra, Jasnoor, Alcantara, Marice, Zengin, Zeynep Busra, Dizman, Nazli, Hsu, Joann, Llamas-Quitiquit, Marian, Castro, Daniela V., Mercier, Benjamin D., Barragan-Carrillo, Regina, Chawla, Neal Shiv, Li, Xiaochen, Liu, Sandy, Chehrazi-Raffle, Alex, Dorff, Tanya B., Frankel, Paul Henry, Tripathi, Abhishek, and Pal, Sumanta Kumar

Published
2024
Full Text
View/download PDF

13. From guidelines to accountability: Examining adherence to ASCO Language of Respect in renal cell carcinoma (RCC) abstracts.

Author

Dizman, Nazli, Castro, Daniela V., Mercier, Benjamin D., Li, Xiaochen, Barragan-Carrillo, Regina, Wong, Megan Hoikei, Chan, Ethan, Dukkipati, Akasha, Paul, Teebro, Faridi, Amber, Patel, Jalen, Goud, Jaya, Paul, Trishita, Zugman, Miguel, Ebrahimi, Hedyeh, Chehrazi-Raffle, Alex, Dorff, Tanya B., Prowell, Tatiana Michelle, Pal, Sumanta Kumar, and Florez, Narjust

Published
2024
Full Text
View/download PDF

14. Development of a patient-centered health-related quality of life (HRQOL) measure for metastatic renal cell carcinoma (mRCC): A three-phase study.

Author

Bergerot, Cristiane Decat, Castro, Daniela V., Bergerot, Paulo Gustavo, Mercier, Benjamin D., Nally, Elizabeth, Ali, Adil A., Philip, Errol James, Buso, Murilo, Hutson, Thomas E., Grünwald, Viktor, Bex, Axel, Psutka, Sarah P., Rini, Brian I., Plimack, Elizabeth R., Master, Viraj A., Albiges, Laurence, Choueiri, Toni K., Pal, Sumanta Kumar, and Powles, Thomas

Published
2024
Full Text
View/download PDF

15. Evaluation of eligibility criteria in contemporary renal cell carcinoma based on ASCO-FCR recommendations.

Author

Prajapati, Sweta R., primary, Feng, Matthew I., additional, Castro, Daniela V., additional, Lee, Kyle O., additional, Chan, Elyse H., additional, Sehgal, Ishaan, additional, Patel, Jalen, additional, O'Dell, Anna, additional, Zengin, Zeynep Busra, additional, Li, Xiaochen, additional, Chehrazi-Raffle, Alex, additional, Dizman, Nazli, additional, Tripathi, Abhishek, additional, Rock, Adam, additional, Liu, Sandy, additional, Mercier, Benjamin D., additional, Meza, Luis A, additional, Philip, Errol James, additional, Dorff, Tanya B., additional, and Pal, Sumanta Monty, additional

Published
2023
Full Text
View/download PDF

16. Prevalence of dietary modification and supplement use in patients with metastatic renal cell carcinoma (mRCC).

Author

Ebrahimi, Hedyeh, primary, Battle, Dena, additional, Zengin, Zeynep Busra, additional, Dizman, Nazli, additional, Meza, Luis A, additional, Castro, Daniela V., additional, Govindarajan, Ameish, additional, Mercier, Benjamin D., additional, Chawla, Neal Shiv, additional, Chehrazi-Raffle, Alex, additional, Tripathi, Abhishek, additional, Liu, Sandy, additional, Vaishampayan, Ulka N., additional, Staehler, Michael D., additional, and Pal, Sumanta Monty, additional

Published
2023
Full Text
View/download PDF

17. Evaluation of eligibility criteria in advanced prostate cancer clinical trials based on ASCO-FCR recommendations.

Author

Feng, Matthew I., primary, Prajapati, Sweta R., additional, Castro, Daniela V., additional, Lee, Kyle O., additional, Chan, Elyse H., additional, Sehgal, Ishaan, additional, Patel, Jalen, additional, O'Dell, Anna, additional, Zengin, Zeynep Busra, additional, Li, Xiaochen, additional, Chehrazi-Raffle, Alex, additional, Dizman, Nazli, additional, Tripathi, Abhishek, additional, Rock, Adam, additional, Liu, Sandy, additional, Mercier, Benjamin D., additional, Meza, Luis A, additional, Philip, Errol James, additional, Dorff, Tanya B., additional, and Pal, Sumanta Monty, additional

Published
2023
Full Text
View/download PDF

18. Assessment of eligibility criteria in advanced urothelial cancer (aUC) trials based on ASCO-FCR recommendations.

Author

Castro, Daniela V., primary, Feng, Matthew I., additional, Prajapati, Sweta R., additional, Chan, Elyse H., additional, Lee, Kyle O., additional, Sehgal, Ishaan, additional, Patel, Jalen, additional, O'Dell, Anna, additional, Zengin, Zeynep Busra, additional, Li, Xiaochen, additional, Chehrazi-Raffle, Alex, additional, Dizman, Nazli, additional, Tripathi, Abhishek, additional, Rock, Adam, additional, Liu, Sandy, additional, Mercier, Benjamin D., additional, Meza, Luis A, additional, Philip, Errol James, additional, Dorff, Tanya B., additional, and Pal, Sumanta Monty, additional

Published
2023
Full Text
View/download PDF

20. Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study

Author

Castro, Daniela V., primary, Zengin, Zeynep B., additional, Malhotra, Jasnoor, additional, Bergerot, Cristiane D., additional, Meza, Luis, additional, Dizman, Nazli, additional, Govindarajan, Ameish, additional, Hsu, JoAnn, additional, Chehrazi-Raffle, Alex, additional, Chawla, Neal, additional, Mercier, Benjamin D., additional, Chen, Sean W., additional, Feng, Matthew, additional, Prajapati, Sweta, additional, Lee, Kyle O., additional, Philip, Errol J., additional, Dorff, Tanya B., additional, Lyou, Yung, additional, and Pal, Sumanta K., additional

Published
2023
Full Text
View/download PDF

21. Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma

Author

Zengin, Zeynep B., primary, Govindarajan, Ameish, additional, Salgia, Nicholas, additional, Sayegh, Nicolas, additional, Tripathi, Nishita, additional, Muddasani, Ramya, additional, Chehrazi-Raffle, Alex, additional, Feng, Matthew, additional, Mercier, Benjamin D., additional, Ladbury, Colton, additional, Hao, Claire, additional, Salgia, Sabrina, additional, Chawla, Neal, additional, Meza, Luis, additional, Malhotra, Jasnoor, additional, Dizman, Nazli, additional, Hsu, JoAnn, additional, Castro, Daniela V., additional, Barragan-Carrillo, Regina, additional, Ebrahimi, Hedyeh, additional, Philip, Errol J., additional, Chang, Mark, additional, Zhang, Jiaming, additional, Byron, Sara, additional, Lyou, Yung, additional, Dorff, Tanya, additional, Pal, Sumanta K., additional, and Dandapani, Savita, additional

Published
2023
Full Text
View/download PDF

23. Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.

Author

Ebrahimi, Hedyeh, Meza, Luis A., Lee, Keehoon, Malhotra, Jasnoor, Alcantara, Marice, Zengin, Zeynep Busra, Dizman, Nazli, Govindarajan, Ameish, Hsu, Joann, Llamas-Quitiquit, Marian, Chawla, Neal Shiv, Castro, Daniela V., Mercier, Benjamin D., Liu, Sandy, Chehrazi-Raffle, Alex, Dorff, Tanya B., Frankel, Paul Henry, Li, Xiaochen, Pal, Sumanta Kumar, and Tripathi, Abhishek

Published
2023
Full Text
View/download PDF

24. Association between intra-tumoral microbiome and clinical benefit (CB) from immunotherapy (IO) in patients with metastatic renal cell carcinoma (mRCC).

Author

Meza, Luis A, Choi, Yongwook, Zhang, Jiaming, Dizman, Nazli, Zengin, Zeynep Busra, Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Hsu, Joann, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Castro, Daniela V., Mercier, Benjamin D, Govindarajan, Ameish, Chan, Agnes, Schork, Nicholas, Byron, Sara A., and Pal, Sumanta Kumar

Published
2023
Full Text
View/download PDF

25. Health-related quality of life (HR-QOL) measures in renal cell carcinoma (RCC): Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30, and EQ-5D.

Author

Bergerot, Cristiane Decat, Mercier, Benjamin D, Castro, Daniela V., Bergerot, Paulo Gustavo, Toms, Charlotte, Ali, Adil A, Philip, Errol James, Lages, Dr. Paulo Sergio, Mota, Augusto C. A., Hutson, Thomas E., Grünwald, Viktor, Bex, Axel, Psutka, Sarah P., Rini, Brian I., Plimack, Elizabeth R., Master, Viraj A., Albiges, Laurence, Choueiri, Toni K., Pal, Sumanta Kumar, and Powles, Thomas

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results